mClinica, a Singapore-headquartered healthtech startup that focuses primarily on the pharmacy industry, is looking to raise $20 million in its Series B round, just months after closing its bridge round with US-based Susquehanna International Group (SIG), a top company executive told DealStreetAsia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
